| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/17/2002 | WO2001052791A3 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 01/17/2002 | WO2001049838A3 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 01/17/2002 | WO2001049741A3 A process for isolation of osteopontin from milk |
| 01/17/2002 | WO2001049722A3 New actinobacillus pleuropneumoniae outer membrane protein and its uses |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001047543A3 Activation and inhibition of the immune system |
| 01/17/2002 | WO2001046228A3 Nucleic acid vaccination |
| 01/17/2002 | WO2001046217A3 Synthesis of a potent paramagnetic agonist (epm-3) of the melanocyte stimulating hormone containing amino acid-type stable free radical |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001042299A3 Hepatitis virus sentinel virus i (svi) |
| 01/17/2002 | WO2001040468A3 Molecules of the card-related protein family and uses thereof |
| 01/17/2002 | WO2001040312A3 Naive screening method |
| 01/17/2002 | WO2001037847A3 Nontoxic vernix compositions and method of producing |
| 01/17/2002 | WO2001036619A3 Cloning and characterization of the cap gene promoter |
| 01/17/2002 | WO2001036596A3 Modulation of plant response to abscisic acid |
| 01/17/2002 | WO2001036469A3 Human ceruloplasmin |
| 01/17/2002 | WO2001036461A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/17/2002 | WO2001034819A3 Genes and methods for manipulation of growth |
| 01/17/2002 | WO2001034818A3 Sorghum dwarfing genes and methods of use |
| 01/17/2002 | WO2001034803A3 Crib protein zmse1 |
| 01/17/2002 | WO2001034771A3 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 01/17/2002 | WO2001034769A3 24 human secreted proteins |
| 01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 01/17/2002 | WO2001032706A3 Novel human transporter proteins and polynucleotides encoding the same |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001031011A3 Gene mining system and method |
| 01/17/2002 | WO2001029078A3 Method for production and use of mite group 1 proteins |
| 01/17/2002 | WO2001029072A3 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 01/17/2002 | WO2001027298A3 Sclerotinia-inducible genes and promoters and their uses |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001027144A3 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 01/17/2002 | WO2001026607A3 Smdf and ggf neuregulin splice variant isoforms and uses thereof |
| 01/17/2002 | WO2001025429A3 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 01/17/2002 | WO2001021821A3 Insect-resistant rice plants |
| 01/17/2002 | WO2001021656A3 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 01/17/2002 | WO2001020010A3 Transcriptionally silenced plant genes |
| 01/17/2002 | WO2001016174A3 Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65 |
| 01/17/2002 | WO2001013118A3 Methods and compositions for diagnosis of hepatoma |
| 01/17/2002 | WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 01/17/2002 | WO2001012829A3 Replication deficient baculovirus expression system |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001011033A3 Identification of genes essential for the survival of haemophilus influenzae through genome scanning by transposition mutagenesis |
| 01/17/2002 | WO2001007613A3 Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2001001786A3 Methods and means for producing improved dairy products |
| 01/17/2002 | WO2001000669A3 A bap28 gene and protein |
| 01/17/2002 | WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO2000077192A9 Reg-binding protein |
| 01/17/2002 | WO2000068249B1 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor |
| 01/17/2002 | WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 01/17/2002 | US20020007501 Protein; for use in the generation of stress, insect and disease resistant plants |
| 01/17/2002 | US20020007498 P2x7 receptor-deficient non-human animals and uses thereof |
| 01/17/2002 | US20020007496 Methods for identifying novel therapeutics and diagnostics in the p53 pathway |
| 01/17/2002 | US20020007173 Method of inducing a CTL response |
| 01/17/2002 | US20020007051 Producing population of hybrid nucleic acid molecules via mixing populations of nucleic acid molecules containing multiple recombination sites; genetic engineering; gene expression |
| 01/17/2002 | US20020007048 Solution Phase Biopolymer Synthesis |
| 01/17/2002 | US20020007047 Polypeptide; for use in the diagnosis and treatment of inflammation, cancer, immunological defects and arthritis |
| 01/17/2002 | US20020006914 Enhancing the sensitivity of tumor cells to therapies |
| 01/17/2002 | US20020006905 Use of botulinum toxins for treating various disorders and conditions and associated pain |
| 01/17/2002 | US20020006903 Genetic engineering |
| 01/17/2002 | US20020006894 Nonantigenic stabilizer and physiologically active substance |
| 01/17/2002 | US20020006892 Serum albumin compositions for use in cleansing or dermatological products for skin or hair |
| 01/17/2002 | US20020006665 Ketogulonigenium endogenous plasmids |
| 01/17/2002 | US20020006657 Nucleic acids which encode insect acetylcholine receptor subunits |
| 01/17/2002 | US20020006656 Zcys5: a member of the cystatin superfamily |
| 01/17/2002 | US20020006649 Matrix; for use in wound healing |
| 01/17/2002 | US20020006641 Increasing production of proteins in gram-positive microorganisms |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006639 Nucleotide sequences coding asthma associated protein; for use in the diagnosis and treatment of genetic disorders associated with inflammation and air passage blockage |
| 01/17/2002 | US20020006638 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
| 01/17/2002 | US20020006637 Particle-mediated transformation of animal tissue cells |
| 01/17/2002 | US20020006630 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers |
| 01/17/2002 | US20020006611 Compositions and methods for differentiating among shigella species and shigella from e. coli species |
| 01/17/2002 | US20020006607 Soild supports for use in monitoring osteogenesis |
| 01/17/2002 | US20020006411 Vaccines expressed in plants |
| 01/17/2002 | US20020006408 Vaccines against eimeria mediated disorder |
| 01/17/2002 | US20020006407 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 01/17/2002 | US20020006397 Delivering a cytotoxic agent which is one or more of herpes simplex virus thymidine kinase (HSV-tk), gancicolvir, or a rejection antigen, into a antigenic biniding protein APBP molecule to induce lysis of target cell |
| 01/17/2002 | US20020006395 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 01/17/2002 | US20020006391 Genetic engineering |
| 01/17/2002 | EP1144666A3 Replication deficient baculovirus expression system |
| 01/17/2002 | DE10031744A1 Mit Blutplasma verträgliche, vernetzte und mit Polyalkylenoxiden konjugierte Säugetierhämoglobine als künstliche medizinische Sauerstoffträger, ihre Herstellung und ihre Verwendung With blood plasma compatible, networked and conjugated with polyalkylene oxides mammalian hemoglobins as artificial medical oxygen carriers, their preparation and their use |
| 01/17/2002 | CA2658217A1 Expression system |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2416224A1 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | CA2416219A1 Artificial antibody polypeptides |
| 01/17/2002 | CA2416203A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | CA2415967A1 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/17/2002 | CA2415919A1 Reagents and methods for identification of binding agents |
| 01/17/2002 | CA2415902A1 Protein design automation for designing protein libraries with altered immunogenicity |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415787A1 Method for determining three-dimensional protein structure from primary protein sequence |
| 01/17/2002 | CA2415763A1 Production of chimeric human papillomavirus |
| 01/17/2002 | CA2415569A1 Fungal cell wall synthesis gene |
| 01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | CA2415478A1 Compounds targeted to cellular locations |
| 01/17/2002 | CA2415464A1 Method for the production of hydroxylated collagen-like compounds |
| 01/17/2002 | CA2415425A1 Insulin derivatives and synthesis thereof |